Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Observation × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 4 Lung Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Trauma, Nervous System 1 Thoracic Injuries 1 Surgical Wound Dehiscence 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Radiculopathy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Pilonidal Sinus 1 Pathologic Complete Response 1

Interventions

fludarabine 8 Specimen Handling 8 Biopsy 8 venetoclax 6 Azacitidine 6 Whole-Body Irradiation 5 Busulfan 5 ruxolitinib 4 decitabine and cedazuridine drug combination 4 Cyclophosphamide 4 fludarabine phosphate 3 Tacrolimus 3 Mycophenolic Acid 3 Injections 3 Cytarabine 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 nilotinib 2 asciminib 2 Therapeutics 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Liposomes 2 Granulocyte Colony-Stimulating Factor 2 Decitabine 2 Daunorubicin 2 Cyclosporins 2 CPX-351 2 Blood Specimen Collection 2 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡